Home › Stock analysis › SBRA
Sabra Health Care REIT (SBRA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
SBRA rises 0.6% to $19.29. Closed at $19.29, +0.63% vs the prior close of $19.17. Day range $19.26–$19.67, opened at $19.61.
Last close$19.29+0.63%
Day range19.26–19.67
Open19.61
Volume2.19M
52-week range17.17–22.77
Avg volume (20d)2.57M
SBRA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — SBRA rises 0.6% to $19.29
- Closed at $19.29, +0.63% vs the prior close of $19.17. Day range $19.26–$19.67, opened at $19.61.
- Volume was 2.19M shares, 0.9x its 50-day average of 2.33M.
- Price is -4.0% vs its 50-day average ($20.10) and -3.4% vs its 200-day average ($19.96).
- 52-week range $17.17–$22.77; today's close sits at 38% of that range, 15.3% below the 52-week high.
Oct 14, 2026 — SBRA dips 0.7% to $19.17
- Closed at $19.17, -0.73% vs the prior close of $19.31. Day range $19.09–$19.37, opened at $19.23.
- Volume was 2.21M shares, 0.9x its 50-day average of 2.40M.
- Price is -4.8% vs its 50-day average ($20.13) and -4.0% vs its 200-day average ($19.96).
- 52-week range $17.17–$22.77; today's close sits at 36% of that range, 15.8% below the 52-week high.
Oct 13, 2026 — SBRA rises 0.6% to $19.31, 4 up days in a row
- Closed at $19.31, +0.57% vs the prior close of $19.20. Day range $19.08–$19.53, opened at $19.53.
- Volume was 2.71M shares, 1.1x its 50-day average of 2.43M.
- Price is -4.2% vs its 50-day average ($20.16) and -3.3% vs its 200-day average ($19.96).
- 52-week range $17.17–$22.77; today's close sits at 38% of that range, 15.2% below the 52-week high.
- That makes 4 straight gains.
Oct 12, 2026 — SBRA rises 1.3% to $19.20, 3 up days in a row
- Closed at $19.20, +1.27% vs the prior close of $18.96. Day range $18.86–$19.23, opened at $18.93.
- Volume was 2.01M shares, 0.8x its 50-day average of 2.44M.
- Price is -4.9% vs its 50-day average ($20.19) and -3.8% vs its 200-day average ($19.96).
- 52-week range $17.17–$22.77; today's close sits at 36% of that range, 15.7% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — SBRA rises 0.6% to $18.96
- Closed at $18.96, +0.64% vs the prior close of $18.84. Day range $18.86–$19.09, opened at $18.87.
- Volume was 1.39M shares, 0.6x its 50-day average of 2.48M — lighter than usual.
- Price is -6.3% vs its 50-day average ($20.23) and -5.0% vs its 200-day average ($19.95).
- 52-week range $17.17–$22.77; today's close sits at 32% of that range, 16.7% below the 52-week high.
Oct 8, 2026 — SBRA rises 0.5% to $18.84
- Closed at $18.84, +0.53% vs the prior close of $18.74. Day range $18.58–$19.00, opened at $18.77.
- Volume was 1.99M shares, 0.8x its 50-day average of 2.48M.
- Price is -7.1% vs its 50-day average ($20.27) and -5.6% vs its 200-day average ($19.95).
- 52-week range $17.17–$22.77; today's close sits at 30% of that range, 17.3% below the 52-week high.
Oct 7, 2026 — SBRA dips 2.0% to $18.74, a 3-month low
- Closed at $18.74, -1.99% vs the prior close of $19.12. Day range $18.73–$19.20, opened at $19.16.
- Volume was 2.22M shares, 0.9x its 50-day average of 2.47M.
- Price is -7.9% vs its 50-day average ($20.34) and -6.1% vs its 200-day average ($19.95).
- 52-week range $17.17–$22.77; today's close sits at 28% of that range, 17.7% below the 52-week high.
Oct 6, 2026 — SBRA ends flat (+0.3%) to $19.12
- Closed at $19.12, +0.26% vs the prior close of $19.07. Day range $18.90–$19.19, opened at $19.05.
- Volume was 2.82M shares, 1.1x its 50-day average of 2.46M.
- Price is -6.3% vs its 50-day average ($20.41) and -4.2% vs its 200-day average ($19.95).
- 52-week range $17.17–$22.77; today's close sits at 35% of that range, 16.0% below the 52-week high.
Oct 5, 2026 — SBRA dips 0.5% to $19.07, a 3-month low, 6 down days in a row
- Closed at $19.07, -0.47% vs the prior close of $19.16. Day range $18.99–$19.37, opened at $19.03.
- Volume was 3.71M shares, 1.5x its 50-day average of 2.42M.
- Price is -6.9% vs its 50-day average ($20.47) and -4.4% vs its 200-day average ($19.95).
- 52-week range $17.17–$22.77; today's close sits at 34% of that range, 16.2% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — SBRA ends flat (-0.2%) to $19.16, a 3-month low, 5 down days in a row
- Closed at $19.16, -0.21% vs the prior close of $19.20. Day range $19.01–$19.42, opened at $19.27.
- Volume was 3.06M shares, 1.3x its 50-day average of 2.42M.
- Price is -6.7% vs its 50-day average ($20.54) and -3.9% vs its 200-day average ($19.95).
- 52-week range $17.17–$22.77; today's close sits at 36% of that range, 15.9% below the 52-week high.
- That makes 5 straight losses.
Things to know before you trade SBRA
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: Apr 29, 2026, Feb 12, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.75% (largest 2.6%). That is a relatively calm stock.
- Liquidity: about 2.57M shares (≈$49.56M) trade per day on average.
- 52-week position: $19.29 vs a range of $17.17–$22.77 (38% of the range).
- Dividends: last ex-dividend date Aug 14, 2026 ($0.3/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 2 sales; latest: Richard K Matros sold 200,000 shares on Sep 8, 2026.
- Latest filings: 10-Q Aug 3, 2026; 8-K Aug 3, 2026; 8-K Jul 21, 2026.
- Share count: 255.46M shares outstanding (Jul 27, 2026), +6.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Real Estate Investment Trusts.
SBRA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 19.61 | 19.67 | 19.26 | 19.29 | 2.19M |
| Oct 14, 2026 | 19.23 | 19.37 | 19.09 | 19.17 | 2.21M |
| Oct 13, 2026 | 19.53 | 19.53 | 19.08 | 19.31 | 2.71M |
| Oct 12, 2026 | 18.93 | 19.23 | 18.86 | 19.20 | 2.01M |
| Oct 9, 2026 | 18.87 | 19.09 | 18.86 | 18.96 | 1.39M |
| Oct 8, 2026 | 18.77 | 19.00 | 18.58 | 18.84 | 1.99M |
| Oct 7, 2026 | 19.16 | 19.20 | 18.73 | 18.74 | 2.22M |
| Oct 6, 2026 | 19.05 | 19.19 | 18.90 | 19.12 | 2.82M |
| Oct 5, 2026 | 19.03 | 19.37 | 18.99 | 19.07 | 3.71M |
| Oct 2, 2026 | 19.27 | 19.42 | 19.01 | 19.16 | 3.06M |
| Oct 1, 2026 | 19.58 | 19.64 | 19.15 | 19.20 | 3.21M |
| Sep 30, 2026 | 19.86 | 19.96 | 19.69 | 19.72 | 2.50M |
| Sep 29, 2026 | 19.77 | 19.97 | 19.63 | 19.78 | 2.28M |
| Sep 28, 2026 | 19.85 | 19.96 | 19.69 | 19.82 | 1.86M |
| Sep 25, 2026 | 19.75 | 19.89 | 19.59 | 19.85 | 2.30M |
| Sep 24, 2026 | 19.77 | 20.06 | 19.74 | 19.77 | 2.14M |
| Sep 23, 2026 | 19.78 | 19.91 | 19.66 | 19.69 | 3.03M |
| Sep 22, 2026 | 19.95 | 19.97 | 19.76 | 19.81 | 2.25M |
| Sep 21, 2026 | 19.78 | 20.09 | 19.71 | 19.87 | 2.01M |
| Sep 18, 2026 | 20.07 | 20.10 | 19.69 | 19.74 | 5.47M |
About Sabra Health Care REIT
Sabra Health Care REIT (SBRA) is listed on the Nasdaq and classified by the SEC under “Real Estate Investment Trusts”. Its business address is in TUSTIN, CA. State of incorporation: MD. Fiscal year ends December 31. SEC CIK 1492298.
SBRA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Craig A. Barbarosh | Director | Sep 2, 2026 |
| Catherine Cusack | Director | Sep 2, 2026 |
| Michael J Foster | Director | Sep 2, 2026 |
| Lynne S Katzmann | Director | Sep 2, 2026 |
| Ann Kono | Director | Sep 2, 2026 |
| Richard K Matros | Chair, CEO and President | Sep 9, 2026 |
| Jeffrey A. Malehorn | Director | Sep 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Lourenco Costa | Executive VP, CFO & Treasurer | Sep 2, 2026 |
| Jessica Flores | Executive VP & CAO | Sep 2, 2026 |
| Richard K Matros | Chair, CEO and President | Sep 9, 2026 |
| Talya Nevo-Hacohen | Executive VP, CIO & Treasurer | Dec 2, 2025 |
| Darrin Smith | Executive VP, CIO & Secretary | Sep 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 8, 2026 | Richard K Matros | Sale | 200,000 | $20.83 |
| Mar 25, 2026 | Jessica Flores | Sale | 15,231 | $19.86 |
SBRA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $356.88M | $155.61M | 0.64 | $348.61M |
| Dec 31, 2024 | $284.58M | $126.71M | 0.54 | $310.54M |
| Dec 31, 2023 | $236.15M | $13.76M | 0.06 | $300.57M |
| Dec 31, 2022 | $186.67M | $-77.61M | -0.34 | $315.73M |
| Dec 31, 2021 | $155.51M | $-113.26M | -0.52 | $356.39M |
Latest balance sheet: total assets $5.51B, total liabilities $2.76B, cash $231.58M (as of Jun 30, 2026).
SBRA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $20.61 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $20.35 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $20.25 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $18.20 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $18.41 |
| May 5, 2025 | 8-K Item 2.02 (results) | $17.28 |
| Feb 19, 2025 | 8-K Item 2.02 (results) | $16.55 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $19.40 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
| Nov 6, 2023 | 8-K Item 2.02 (results) | — |
More on SBRA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.